CAGNONI PABLO J 4

What Happened

• Pablo J. Cagnoni, President, R&D at Incyte Corporation, received a derivative award of 28,475 shares on January 16, 2026. The filing reports an acquisition price of $0.00 (derivative grant), so no cash was paid at grant.

Key Details

• Transaction date and price: 2026-01-16; reported price $0.00; transaction coded as "A" (award/grant) and listed as a derivative.
• Shares received: 28,475 shares granted.
• Shares owned after transaction: Not specified in this Form 4 filing.
• Vesting/exercise notes: Footnote indicates these are option-style awards that become exercisable in 37 installments — first 25% vests on July 15, 2026, with the remainder vesting monthly over three years.
• Timeliness: Form 4 was filed on 2026-01-21 for a 2026-01-16 transaction. Given the January 19 federal holiday, the filing date is within the two-business-day reporting window and is timely.

Context

• This was a compensatory derivative grant (award of options/units), a common form of executive compensation. Such grants are routine and do not by themselves indicate an immediate purchase or sale of shares; they vest over time per the schedule above.